Back to Journals » Clinical and Experimental Gastroenterology » Volume 11

Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin

Total article views   Abstract views HTML views PDF downloads Totals
6,281 Dovepress* 4,155 1,305+ 536 5,460
PubMed Central* 0 821 301 821
Totals 4,155 2,126 837 6,281
*Since 24 September 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
14 0 0 0 6 8

View citations on PubMed Central and Google Scholar